The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

HealthSouth Corp

NYSE: HLS
Last

(U.S.) $45.70

Today's change0.00 0.00%
Updated July 31 4:04 PM EDT. Delayed by at least 15 minutes.
 

HealthSouth Corp

NYSE: HLS
Last

(U.S.) $45.70

Today's change0.00 0.00%
Updated July 31 4:04 PM EDT. Delayed by at least 15 minutes.

HealthSouth Corp closed at (U.S.)$45.70.

Shares have lost 1.76% over the last five days, but have gained 18.82% over the last year to date. This security has outperformed the S&P 500 by 10.26% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $45.70
  • High--
  • Low--
  • Bid / Ask(U.S.) $41.76 / (U.S.) $49.59
  • YTD % change+18.82%
  • Volume0
  • Average volume (10-day)876,556
  • Average volume (1-month)703,312
  • Average volume (3-month)811,133
  • 52-week range(U.S.) $35.84 to (U.S.) $48.32
  • Beta1.80
  • Trailing P/E25.62×
  • P/E 1 year forward20.20×
  • Forward PEG2.31×
  • Indicated annual dividend(U.S.) $0.92
  • Dividend yield2.01%
  • Trailing EPS(U.S.) $1.78
Updated July 31 4:04 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9.02%

Based on its net profit margin of 9.02%, HealthSouth Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.60%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue754729607589
Total other revenue--------
Total revenue754729607589
Gross profit722698577562
Total cost of revenue32313027
Total operating expense634610510475
Selling / general / administrative447434349332
Research & development--------
Depreciation / amortization33322827
Interest expense (income), net operating--------
Unusual expense (income)199120
Other operating expenses, total1041039189
Operating income12011997114
Interest income (expense), net non-operating-31-32-26-28
Gain (loss) on sale of assets--------
Other--------
Income before tax94907488
Income after tax62595566
Income tax, total32301922
Net income43434250
Total adjustments to net income0-2-2-2
Net income before extra. items45433951
Minority interest-17-17-15-15
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items44413849
Inc. avail. to common incl. extra. items43414048
Diluted net income43414452
Dilution adjustment----44
Diluted weighted average shares102101101101
Diluted EPS excluding extraordinary itemsvalue per share0.440.400.410.53
Dividends per sharevalue per share0.210.210.210.21
Diluted normalized EPSvalue per share0.560.450.500.55